Dr George Frodsham presents MediSieve at the Royal Society of Medicine's 12th Medical Innovations Summit 

Dr George Frodsham, founder and CEO of MediSieve, presented at the Royal Society of Medicine's 12th Medical Innovations Summit in April. 

The prestigious event saw the entrepreneur behind the groundbreaking magnetic sieve that removes malaria-infected blood cells speak about his innovative alternative to drug treatments. Discussing how half the world is at risk of malaria, with one child dying of the disease every minute, he explained the magnetic properties of malaria and demonstrated how the device targets it. Dr Frodsham gave attendees an insight into the experimental results and the current state of the technology. He concluded his talk by exploring the future potential of Medisieve and his vision for it.

Treatment with MediSieve’s device involves no drugs or chemicals and offers new hope for malaria patients whose cases are severe or resistant to existing medicines. Initial trials show that magnetic blood filter could extract up to 90 per cent of infected cells from a person with malaria in under four hours.

Red blood cells infected with a malaria parasite have magnetic properties. This enables MediSieve’s device to capture them without affecting healthy cells. The process is similar to dialysis in that infected cells are captured as blood passes through an external loop. Rapid removal of infected cells has the potential to turn back the clock on severe malaria reducing symptoms, severity and mortality.

Dr Frodsham also features in Doctors of the Future, a new online news and current affairs style programme created jointly between the Royal Society of Medicine and ITN Productions. The programme explores how the innovators of tomorrow are facing global health challenges. It will stimulate debate, champion medical education, celebrate innovation and promote the exchange of ideas. Editorial content will include interviews, news-style reports and sponsored profiles of leading healthcare organisations.

Scientists are increasingly concerned about drug resistant strains of malaria. Today, three of the five strains of the disease that affect humans can resist antimalarials – and they’re spreading across Cambodia, Laos, Thailand, Vietnam and Myanmar.

Very often, malaria is untreatable, either because diagnosis is too late or the strain is resistant to drugs currently available.

MediSieve’s treatment could be used when drugs become ineffective or to supplement existing drug treatments. The magnetic device could help patients manage malaria and keep symptoms at bay indefinitely.

The Royal Society of Medicine's Medical Innovations Summits provide twice-yearly platforms for ideas and developments in medicine and healthcare. They inspire innovators at the very beginning of their careers as well as established clinicians and academics. To find out more, visit http://www.rsm-medicalinnovations.com.

For more information about MediSieve, visit www.MediSieve.com and follow on Twitter.To watch Dr Frodsham’s talk at the Royal Society of Medicine's 12th Medical Innovations Summit, visit https://videos.rsm.ac.uk/video/medisieve-magnetic-blood-filtration. 

To view Doctors of the Future, visit https://www.rsm.ac.uk/about-us/latest-news/doctors-of-the-future.aspx.

Ends